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Abstract
Dendritic cells (DCs), which are essential for initiating immune responses, are comprised of
different subsets. Tetraspanins organize dendritic cell membranes by facilitating protein-
protein interactions within the so called tetraspanin web. In this study we analyzed expres-
sion of the complete tetraspanin superfamily in primary murine (CD4+, CD8+, pDC) and
human DC subsets (CD1c+, CD141+, pDC) at the transcriptome and proteome level. Differ-
ent RNA and protein expression profiles for the tetraspanin genes across human and murine
DC subsets were identified. Although RNA expression levels of CD37 and CD82 were not
significantly different between human DC subsets, CD9 RNA was highly expressed in
pDCs, while CD9 protein expression was lower. This indicates that relative RNA and protein
expression levels are not always in agreement. Both murine CD8α+ DCs and its regarded
human counterpart, CD141+ DCs, displayed relatively high protein levels of CD81. CD53
protein was highly expressed on human pDCs in contrast to the relatively low protein
expression of most other tetraspanins. This study demonstrates that tetraspanins are differ-
entially expressed by human and murine DC subsets which provides a valuable resource
that will aid the understanding of tetraspanin function in DC biology.
Introduction
Dendritic cells (DCs) are highly specialized immune cells that can sense tumor and microbial
antigens and initiate both cellular and humoral immune responses. The complexity of the DC
network has expanded enormously in the last decade by the identification of multiple different
DC subsets. These subsets have been characterized by ontogeny, anatomical location, pheno-
typical markers, gene expression programs, and functionality [1,2]. The remarkable heteroge-
neity in DC subtypes may underlie a broad variety in the type, strength and duration of
immune responses that may lead to either immunity or tolerance.
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The DC network is largely conserved between mouse and human, although subset-discrim-
inatory (cell surface) markers are different between the two species. In human peripheral
blood, DC subsets are classified into plasmacytoid DCs (pDCs, BDCA4+) and two myeloid
DC subsets: CD141+ (BDCA3+) and CD1c+ (BDCA1+) cells, also referred to as classical DC1
(cDC1) and cDC2, respectively [3]. These DC subsets are not only present in blood but have
also been detected in different human lymphoid and non-lymphoid organs. In contrast to
humans, for practical reasons murine DCs have mostly been studied in lymphoid organs such
as the spleen, rather than in blood, and include plasmacytoid DCs (pDCs, CD11c int, B220+)
and two myeloid DC subsets: CD8α+ (CD11b- CD11c+) DCs and CD4+ (CD11b+ CD11c+)
DCs [4,5]. Although there are both phenotypical and anatomical differences between murine
and human DC subsets, they share many functional properties [6]. Both human and murine
pDCs have the capacity to produce vast amounts of type I interferons (IFNα and IFNβ) and as
such are important in the induction of antiviral immune responses. The cDC1 subsets (human
CD141+ and murine CD8α+ DCs) share the ability to mediate efficient antigen cross-presen-
tation leading to activation of CD8+ T cells, whereas the cDC2 subsets are more efficient in
stimulating CD4+ T cell responses and polarization towards Th2 and Th17 responses [2].
DCs interact with their environment (i.e. tissue surroundings, pathogens/tumor cells and
other immune cells) through immunoreceptors that are embedded in the plasma membrane.
It is well-established that these immunoreceptors (including major histocompatibility complex
(MHC) molecules, pattern-recognition receptors (PRRs) and adhesion proteins) are non-ran-
domly distributed at the cell surface and organized in domains. This organization not only
increases receptor avidity, but also allows for receptor cross-talk and spatial regulation of
receptor signaling. For example, MHC-peptide complexes on DCs are pre-clustered, permit-
ting simultaneous engagement of multiple T cell receptors (TCRs) to overcome the required
signaling threshold for T cell activation [7–10]. Clustering of immunoreceptors in DCs occurs
in several specialized membrane domains, including caveolae, lipid rafts, and tetraspanin-
enriched microdomains that each have a distinct organization and function [11–16]. In this
study, we focused on the organizers of the latter domain, the tetraspanins, which are widely
expressed but so far have been little studied in DC subsets.
Tetraspanins belong to the superfamily of four-transmembrane proteins that share a CCG
motif and conserved cysteine residues in the large extracellular loop [17,18]. They are
expressed on the plasma membrane as well as on intracellular membranes. Tetraspanins are
not classical ligand-binding receptors that bind ligands in trans, instead they mostly interact
with other proteins in cis. Documented binding partners include different immunoreceptors
(MHC, CD4, CD8, C-type lectin receptors, and others), integrins and signaling proteins, and
tetraspanins regulate their lateral organization [14,19]. It has been estimated that DCs express
approximately 20 tetraspanins of the 33 different family members that have been identified in
mammalian cells [20,21]. Despite the essential role of cell surface receptors for DC function,
studies on the role of tetraspanin proteins in regulating DC receptors have only recently been
initiated. We and others have shown that DC migration is regulated by tetraspanins CD37 and
CD81. CD81 was found to be required for the formation of membrane protrusions during
adhesion-dependent DC migration, and CD37-deficiency leads to impaired DC migration
from skin to lymph nodes in mice [22,23]. In contrast, the predominantly intracellularly
expressed tetraspanin CD63 may slow down DC migration via a mechanism that is yet unclear
[24]. Other studies have reported on the involvement of tetraspanins (CD37, CD151, CD9,
CD81, CD82) in antigen presentation by DCs by regulating MHC interactions, the formation
of the immune synapse, or through exosomes [25–29].
Together these studies underscore that tetraspanins play an important role in regulating
DC surface receptor function. The different DC subsets differ greatly in the set of surface
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receptors they express [30], and consequently may require a distinct set of tetraspanins for
receptor regulation. Moreover, variation in expression of tetraspanins between DC subsets
could equip DCs with cell specific functions by differential regulation of the same cell surface
receptor in one DC subset with respect to other subsets. Here, we directly compared the
expression of the complete tetraspanin superfamily in primary murine and human DC subsets
at the RNA and protein level and discuss potential implications for DC biology.
Materials and methods
Microarray data
For RNA analysis, publically available affymetrix CEL files containing expression data of rest-
ing blood derived human pDCs, CD1c+ and BDCA3 (CD141+) mDCs were downloaded from
ArrayExpress (accession: E-TABM-34). The FACS sorting and subsequent sample preparation
and analysis is described in the associated study by Lindstedt et al. [31]. For mouse DCs,
expression data generated as part of the Immunological Genome Project (Immgen) of resting
spleen derived-pDCs (GSM605840-GSM605842), CD8α DCs (GSM538258-GSM538260) and
CD4+ DCs (GSM538248-GSM538250) was used (GSE 15907) [32]. Data were downloaded
from the Gene Expression Omnibus. Sample preparation, gating and analysis is described in
detail on the Immgen website (http://www.immgen.org).
The raw files were processed in the R programming environment and intensity values were
normalized using the RMA normalization function of the affy package [33]. The normalization
was evaluated by boxplots (S1 Fig). Specific annotation packages for human (hgu133plus2.db)
and mouse (mogene10sttranscriptcluster.db) were used to map array probe identifiers to cor-
responding species specific Gene Symbols. When multiple Probesets target the same gene,
only one ProbeSet was included in the final dataset. In these cases, the ProbeSet with the high-
est summed intensity across all samples was selected. From the curated tetraspanin genes sets
(http://www.genenames.org/genefamilies/TSPAN) we were able to retrieve 32 tetraspanins in
the human dataset and 31 tetraspanins in the mouse dataset. For genes with an expression
level below 5 we did not find any ANOVA significant differences. Because of the increasing
influence of background noise these data were considered less reliable. Therefore genes with
expression levels below 5 in 2-out-of-3 donors in all DC subsets (6 genes in the human set and
2 genes in the mouse set) were not presented in the main results and are only included in
S1 Table, which provides the probe identifiers, RNA expression levels and statistical analyses
of all members of the tetraspanin family.
ANOVA was applied on the 2log-transformed values of the retrieved tetraspanins for
human and mouse data separately. p-values were corrected for multiple testing using the Ben-
jamini & Hochberg correction. Genes with a resulting p-value<0.05 were considered as differ-
entially expressed and subjected to further post hoc t-testing. For the generation of heat maps,
human and murine datasets were separately z-scored (setting the data to a mean = 0 and a vari-
ance = 1), and heat maps were generated using freely availably GeneE program (http://www.
broadinstitute.org/).
Cells
Human blood peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats by
Ficoll density centrifugation (Lucron Bioproducts). Buffy coats of healthy individuals (San-
quin) were obtained after written informed consent and according to institutional guidelines
and the Helsinki declaration. This was verified by the local institutional review board (Com-
missie mensgebonden onderzoek (CMO)). Mice of the C57Bl/6j background were bred in the
Central Animal Laboratory of the Radboud university medical center, and sacrificed by
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cervical dislocation or exposure to rising concentrations of CO2. Single cell suspensions of
murine spleens were made by DNAse and collagenase treatment, after which DCs were
enriched by Nycodenz density centrifugation as described in [34]. All murine studies complied
with European legislation (directive 2010/63/EU of the European Commission) and these
studies were approved by local authorities (CCD, The Hague, the Netherlands) for the care
and use of animals with related codes of practice.
Flow cytometry
Antibodies used in this study are listed in S3 Table. Human PBMCs were stained with viability
dye e780 in phosphate buffered saline (PBS) before fixation with 2% paraformaldehyde (PFA)
in PBS. Murine cells were fixed with 4% PFA. Cells were permeabilized with 0.5% saponin
(Sigma) in PBS with 1% BSA and 0.05% NaN3 (PBA). Cells were blocked and stained in 1%
human serum (human cells) or 2% goat serum (murine cells), 0.5% saponin in PBA. First, cells
were stained with anti-tetraspanin antibodies or isotype controls, followed by labelled second-
ary antibodies. Next, free arms of bound secondary antibodies were blocked with mouse or
rabbit serum, and subsequently stained with antibodies for DC subset identification. The gat-
ing strategy for identification of DC subsets was similar to the gating strategy used for the cell
isolation for RNA analysis [31,32]. Human PBMCs were analyzed on the FACSVerse (BD Bio-
sciences) and murine cells on the FACSCalibur (BD Biosciences). Data analysis was done
using FlowJo software (version 9.7, TreeStar Inc.). For statistical analysis of flow cytometry
data the mean fluorescent intensities (MFI) of isotype control stainings were first subtracted
from the specific stainings. In some cases this resulted in negative values. To allow log transfor-
mation for further statistical analysis all values were then increased with the lowest possible,
for each protein different, set value that would render all values for that protein positive and
resulting values were subsequently 2log transformed. Three-group ANOVA was then applied
on the 2log-transformed mean fluorescence intensity values for human and mouse datasets
separately. ANOVA p-values were corrected for multiple testing using the Benjamini & Hoch-
berg procedure. Genes with a corrected p-value <0.05 were considered as differentially
expressed and subjected to further post hoc t-testing.
Results
Tetraspanins are differentially expressed by human DC subsets
RNA expression data of tetraspanins in human DCs subsets was retrieved from a publically
available dataset [31], which provides relative mRNA expression levels of tetraspanin super-
family members in CD1c+ DCs, CD141+ DCs and pDCs derived from the blood of 3 healthy
donors. From these files we were able to identify 32 different tetraspanins expressed by human
DCs of which 6 were excluded from the analyses due to low expression levels (< 5 in 2-out-of-
3 donors) which prevented reliable assessment of differential expression between subsets.
Information on these tetraspanins that were hardly detectable is included in S1 Table.
From the resulting 26 different human tetraspanins, 16 appeared differentially transcribed
between the DC subsets (Fig 1A; S1 Table). The expression profiles differed greatly between
the tetraspanin genes: CD9, CD53, TSPAN1, TSPAN3, TSPAN13 and TSPAN31 were relatively
high expressed in pDCs compared to CD1c+ DCs and CD141+ DCs, whereas the other tetra-
spanin genes displayed higher mRNA levels in mDC subsets compared to pDCs (CD63,
CD151, TSPAN17). In addition, several tetraspanin genes were differentially transcribed
between mDC subsets CD1c+ and CD141+ DCs (e.g. CD53, CD81, TSPAN2, TSPAN4,
TSPAN14). For the tetraspanin genes depicted in Fig 1B the expression pattern between DC
subsets was much less consistent and concordantly no significant differences in their mRNA
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expression levels between the different DC subsets were found. Based on the microarray data,
our specific interest and the availability of antibodies, we selected 7 tetraspanin genes for in-
depth analysis. Plotting of the untransformed RNA expression levels of these tetraspanins
highlighted that although CD9 was remarkably high expressed in pDCs compared to the other
subsets, differences in expression levels between the DC subsets were generally small, but con-
sistent between the different donors (CD53, CD81, CD151 and TSPAN31). mRNA expression
levels of CD37 and CD82 were not significantly different between DC subsets, but are of inter-
est for further analysis because of their potential roles in antigen presentation and migration
that are key to DC function [22,23] (Fig 1C).
Fig 1. Relative mRNA expression levels of tetraspanins in human DC subsets. Z-scored values of (A) differentially expressed genes (ANOVA
p<0.05) and (B) non-differentially expressed genes (ANOVA p>0.05 and expression >25 in at least two donors in one DC subset). Asterisks mark genes
that were selected for further analysis. See S1 Table for selected probes and statistics on expression data of all members of the tetraspanin family. (C)
Gene expression levels of tetraspanins in DC subsets, normalized probe intensities are plotted, each symbol represents one healthy donor. P-values
displayed above each plot represent the result of ANOVA to which multiple testing correction was been applied (n.s. = non-significant). * p<0.05,
** p< 0.01 ***p<0.001 by post-hoc t-testing. See also S1 Table for full results of the statistical analysis.
https://doi.org/10.1371/journal.pone.0184317.g001
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Next, for the selected set of 7 tetraspanins on human DC subsets, we investigated whether
RNA expression values were indicative of protein expression levels. Total protein expression
levels were measured on CD1c+ DCs, CD141+ DCs and pDCs by flow cytometry. Gating strat-
egies for the identification of these DC subsets were matched to those used for DC subset cell
isolation in the RNA dataset [31]. For most tetraspanins, the observed differential expression
between the DC subsets at the mRNA level was confirmed at the protein level (Fig 2A;
Table 1). The protein data, however, was not always in agreement with the RNA expression
data. We observed a lower CD9 and CD82 protein expression on pDCs compared to CD1c+ or
CD141+ DCs and equal levels of TSPAN31 (Fig 2B), which was in contrast to their relative
Fig 2. Protein expression of tetraspanins on human DC subsets. (A) Flow cytometric analysis of total tetraspanin protein expression on fixed
permeabilized DC subsets. Far left: dot plots of viable Lin-MHC II+ cells. CD1c+ DCs were identified as BDCA1+, CD141+ DCs as BDCA3+, and pDCs as
BDCA4+ cells. See S2 Fig for full gating strategy. Histograms of tetraspanin expression (black curve) and isotype control staining (grey curve) on gated
cells depicted in the dot plots. (B) Tetraspanin expression of 3 healthy donors, geometric mean fluorescence intensity (gMFI) normalized for isotype
control binding, each symbol represents one donor. P-values displayed above each plot represent the result of ANOVA to which multiple testing correction
was been applied (n.s. = non-significant). * p<0.05, ** p< 0.01 ***p<0.001 by post-hoc t-testing. See also S2 Table for full results of the statistical
analysis.
https://doi.org/10.1371/journal.pone.0184317.g002
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mRNA expression levels in pDCs. These results indicate that CD9, CD82 and TSPAN31 pro-
tein expression in pDCs is possibly modulated by decreased mRNA stabilisation and/or
increased protein degradation. For the other tetraspanins studied, mRNA and protein levels
were largely in agreement (Table 1). Although CD37 protein expression varied greatly between
donors, similar expression levels were found between the DC subsets of each donor. CD53 was
highly expressed in pDCs which was in sharp contrast to the relatively low protein expression
levels of most other tetraspanins on pDCs (CD9, CD81, CD82 and CD151). CD81 was
markedly higher expressed on CD141+ DCs compared to the other DC subsets, and CD151
protein expression was highest on CD1c+ DCs closely followed by CD141+DCs and much
lower on pDCs.
Tetraspanins are differentially expressed by murine DC subsets
To investigate the conservation of tetraspanin expression in the murine DC-subset equivalents,
we retrieved mRNA expression data of tetraspanins for spleen-derived CD11b+CD4+DCs,
CD11b-CD8α+ DCs and pDCs from the public ImmGen repository [32]. Within the DC sub-
set data containing mRNA expression from 3 mice 31 tetraspanin genes were identified, of
which 29 different tetraspanin genes met the selection criteria to be analyzed further. 17 tetra-
spanin genes were found to be differentially transcribed between the different DC subsets
(Fig 3A; S1 Table). Similar to their human counterparts, these murine tetraspanin genes
showed different expression profiles across the DC subsets. Cd37, Cd53, Tspan5, Tspan13,
Tspan14 and Tspan31 were relatively high expressed in pDCs, whereas many other tetraspanin
genes demonstrated higher mRNA levels in mDCs compared to pDCs (Fig 3A). Interestingly,
differences in relative tetraspanin expression between CD4+ and CD8α+ DCs seemed less pro-
nounced than the differences observed between the human mDC counterparts. The tetraspa-
nin genes depicted in Fig 3B were not found to be differentially expressed between the DC
subsets. In contrast to the human RNA profile, but in line with the human protein data, Cd9
was expressed at relatively low levels on pDCs compared to CD4+ and CD8α+ DCs (Fig 3C).
Cd53 was expressed at relatively high levels on murine pDCs and Cd81 on CD8α+ DCs, which
matched the human CD53 and CD81 expression profiles.
Subsequently we measured the protein expression levels of selected tetraspanins for the
murine DC subsets. Gating strategies for the identification of CD11b+CD4+ DCs, CD11b-
CD8α+ DCs and pDCs were matched to those used for DC subset cell isolation in the RNA
dataset [32]. Due to limited availability of antibodies recognizing mouse tetraspanins the anal-
ysis was restricted to total protein expression of CD9, CD53, CD81 and CD151 (Fig 4A). Nota-
bly, CD9 and CD81 were absent on pDCs which is line with the human data (Fig 2). In
Table 1. Tetraspanin protein expression on DC subsets.
Human Mouse
CD9 D pDC low A CD8α+ DC high, pDC very low
CD37 A Similar expression N.A.
CD53 A pDC high D pDC low
CD81 A CD141+ DC high, pDC very low A CD8α+ DC high, pDC very low
CD82 D pDC low N.A.
CD151 A pDC low D CD4+ DC low, CD8α high
Tspan31 D Similar expression N.A.
D: RNA and protein expression profile disagree. A: RNA and protein expression profile agree. N.A.: not
analyzed. Remarks on the relative protein expression profile of each tetraspanin are described.
https://doi.org/10.1371/journal.pone.0184317.t001
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contrast, CD8α+ DCs displayed relatively high protein levels of these tetraspanins (Fig 4B),
which was again similar to our observations in human CD141+ mDCs. On the other hand, the
expression pattern of CD53 differed greatly between murine mRNA and protein data as well
as between murine and human protein data (Table 1). Opposite to the relatively high Cd53
mRNA levels, lower protein levels of CD53 were observed on murine pDCs, compared to
CD4+ and CD8α+ DCs. This indicated that also CD53 protein expression levels are not solely
Fig 3. Relative mRNA expression levels of tetraspanins in murine DC subsets. Z-scored values of (A)
differentially expressed genes (ANOVA p<0.05) and (B) non-differentially expressed genes (ANOVA p>0.05
and expression > 25 in at least two mice in one subset). Asterisks mark genes that were selected for further
analysis. See S1 Table for selected probes and statistics on expression data of all members of the tetraspanin
family. (C) Gene expression levels of tetraspanins in DC subsets, probe intensities are plotted, each symbol
represents one mouse. P-values displayed above each plot represent the result of ANOVA to which multiple
testing correction was been applied (n.s. = non-significant). * p<0.05, ** p< 0.01 ***p<0.001 by post-hoc t-
testing. See also S1 Table for full results of the statistical analysis.
https://doi.org/10.1371/journal.pone.0184317.g003
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Fig 4. Protein expression of tetraspanins on murine DC subsets. (A) Flow cytometric analysis of total tetraspanin protein expression on DC subsets.
Cells from spleen were enriched for DCs as described in the materials and methods. Far left: dot plots of viable CD11c+ cells (CD4+ and CD8α+ DCs) or
viable pDCs. CD4+ DCs were identified as CD4+CD11b+, CD8α+ DCs as CD8α+CD11b-, and pDCs as B220+CD11cint cells. See S3 Fig for full gating
strategy. Histograms of tetraspanin protein expression on gated cells depicted in the dot plots (black line) and isotype controls (grey line). (B) Average
tetraspanin expression of 3 individual mice, geometric mean fluorescence intensity (gMFI) normalized for isotype control binding, each symbol represents
one mouse. P-values displayed above each plot represent the result of ANOVA to which multiple testing correction was been applied (n.s. = non-
significant). * p<0.05, ** p< 0.01 ***p<0.001 by post-hoc t-testing. See also S2 Table for full results of the statistical analysis.
https://doi.org/10.1371/journal.pone.0184317.g004
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regulated by the amount of mRNA. Similarly, CD151 protein expression on murine pDCs was
in the same range as CD151 expression on the other DC subsets, in contrast to the low Cd151
expression levels on pDCs measured at the mRNA level.
Discussion
Here, a complete overview of expression of members of the tetraspanin superfamily is pro-
vided in human and murine DC subsets at both the mRNA and protein level. We demonstrate
that many tetraspanins are differentially expressed between cDC1s, cDC2s and pDCs,
indicating they may have a role in sustaining subset identity or functional differences. More-
over, different expression profiles were found between individual tetraspanin genes, which
may reflect the reported non-redundant functions of members of the tetraspanin superfamily
[14,19,35].
We are aware of the limitations of our study (e.g. small sample size, variation between
donors), and as a result we did not obtain clear results in all cases (human CD9, CD53).
Despite these limitations however, consistent tetraspanin protein expression patterns between
DC subsets throughout the donors tested were identified for several tetrapanins (human
CD81, CD82, CD151; Murine CD9, CD53, CD81, CD151) while for others our results consis-
tently indicate that no large differences may exist (human CD37, CD53, Tspan31) (Figs 1A
and 3A). These results represent a good starting point for further tetraspanin research on DC
subsets.
Although for most tetraspanins RNA and protein data were in agreement we identified also
several cases where protein expression and RNA expression were not consistent (human CD9,
CD82, Tspan31; murine CD53, CD151; Table 1). Because we used publically available microar-
ray data this could be caused by the fact that we did not use data from the exact same cells,
despite the well-matched gating strategy. Our recent observation that the correlation between
RNA and protein expression across different isolates of the same cell types from different indi-
viduals is very well preserved [36] however, argues that this may not be the primary explana-
tion for this discrepancy. Possibly, posttranscriptional regulatory mechanisms are involved in
regulating RNA translation and protein stability for these tetraspanins.
Although DC subsets share their function as professional antigen-presenting cells, they are
highly specialized when it comes to pathogen recognition, antigen uptake and processing, T cell
co-stimulation, cytokine secretion and migratory routes. All these processes are regulated by
transmembrane proteins and downstream intracellular signaling cascades. After antigen
uptake, DCs migrate towards lymph nodes to activate naïve T lymphocytes. Within the lymph
node DCs present non-self peptides to CD4+ T cells on MHC class II, or to CD8+ T cells on
MHC class I molecules. The interaction between MHC class II and tetraspanins (CD9, CD37,
CD53, CD63, CD81 and CD82) is well documented [15]. It has been suggested that tetraspanins
regulate both plasma membrane stability and intracellular trafficking and loading of MHC mol-
ecules [37,38]. The relative low expression of tetraspanins (CD9, CD81, CD82) on pDCs may
reflect a regulatory role for these tetraspanins in processes that are important in cDC function,
such as phagocytosis [39], antigen processing [40] or MHC class II trafficking [41].
Although CD141+ DCs are able to present antigen via MHC class II to CD4+ T cells, they
stand out in their ability to efficiently cross-present antigens from dying or virus infected cells
via MHC class I to CD8+ T cells. CD53, CD81 and CD82 have been reported to interact with
MHC class I [42], and it will be interesting to study the role of these tetraspanins in antigen
cross-presentation or receptor mediated uptake of remnants of dying cells by CD141+ DCs
and CD8α+ DCs. CD81 is of particular interest, since we observed CD81 to be highly
expressed in both human CD141+ DCs and murine CD8a+ DCs.
Differential expression of tetraspanin superfamily members in dendritic cell subsets
PLOS ONE | https://doi.org/10.1371/journal.pone.0184317 September 7, 2017 10 / 15
Notable was the relative high protein expression of tetraspanin CD53 on all human DC sub-
sets and in particular on human pDCs. This result is in line with our recent comparative prote-
ome analysis of human DC subsets that indicated higher CD53 expression on pDCs [36].
CD53 is exclusively expressed on cells of the hematopoietic system and highly expressed on
antigen-presenting cells [43]. pDCs differ from the other DC subsets by their unique expres-
sion of virus recognizing PRRs, their ability to secrete high amounts of type I interferon, and
their unique migratory and adhesive properties. We observed that pDCs expressed relatively
low protein levels of many tetraspanins, even though mRNA levels were high (CD9, CD81,
CD82). It is possible that pDCs, more than the other DC subsets, regulate tetraspanin protein
expression via additional mechanisms like posttranslational modifications, protein and/or
RNA degradation or microRNAs. In colorectal carcinoma, Tspan1 mRNA is targeted by
microRNA-638 suggesting that some tetraspanins are prone to this latter regulatory mecha-
nism [44]. Moreover, tetraspanin expression levels have been reported to change upon activa-
tion and differentiation of other immune cells [45], thus it would be valuable to investigate
differential expression of tetraspanins in DCs during differentiation and activation. This is
illustrated by a recent study on CD37 and CD82 expression and function on immature and
mature murine bone marrow derived DCs. CD37, which promotes migration but restrains
antigen presentation, is down-regulated upon DC maturation, whereas CD82, which restrains
migration but promotes antigen presentation, is up-regulated in mature DCs [46].
The expression pattern of tetraspanins in DC subsets was not always conserved between
human and mouse, as shown here for CD53 and CD151. This may be due to the different ana-
tomical location the subsets were obtained from (i.e. blood versus spleen), and the resulting
differential need for integrin activity. Tetraspanins are known to control integrin avidity and
its downstream signaling events [22,47]. On B cells, CD37 controls integrin α4β1 clustering
and function, leading to defective AKT kinase signaling and increased apoptosis of B cells in
the absence of CD37 [48]. Moreover, CD37-deficient dermal DCs show impaired directional
migration to draining lymph nodes, which contributes to the poor cellular immune responses
observed in Cd37-/-mice [23]. CD151 strongly interacts with and modulates the function of
laminin-binding integrins, thereby affecting cell adhesion and migration [49,50]. This is
apparent in Cd151-/-mice that are impaired in wound healing [51], and are protected against
tumor cell metastasis [52]. It would be interesting to investigate whether differential expression
of CD151 in DC subsets influences integrin-dependent DC adhesion and migration.
Due to their interactions with various immune receptors and adhesion molecules, tetraspa-
nins play important and diverse roles in many immunological processes including antigen pre-
sentation, cell adherence and cytokine production. This study on tetraspanin expression on
the different DC subsets, combined with increased understanding into specific functions of
DC subsets provides a valuable resource to elucidate which biological processes are regulated
by individual tetraspanins.
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S1 Fig. Data normalization. Box plots of normalized probe intensity distributions. Complete
data set of expression values of human blood DC subsets (A) and murine spleen DC subsets
(B) were normalized using the RMA normalization function and 2log transformation.
(TIF)
S2 Fig. Gating strategy human DC subsets. PBMCs were stained with specific antibodies and
analyzed by flow cytometry. (A) Cell debris (left) and cells positive for dead cell marker were
excluded (middle). DCs positive for MHC class II and negative for lineage markers CD3,
CD14, CD16, CD19, CD20 and CD56 were selected (right). (B) CD1c+ DCs were gated on
MHC class II and BDCA1 positivity (left). Cells positive for BDCA3 and BDCA4 were
excluded (right) from tetraspanin expression analysis. (C) CD141+ DCs were gated on MHC
class II and BDCA3 positivity (left). Cells positive for BDCA1 and BDCA4 were excluded
(right) from tetraspanin expression analysis. (D) pDCs were gated on MHC class II and
BDCA4 positivity (left). Cells positive for BDCA1 and BDCA3 were excluded (right) from tet-
raspanin expression analysis.
(TIF)
S3 Fig. Gating strategy murine DC subsets. Splenic cells were enriched for DCs, stained with
specific antibodies and analyzed by flow cytometry. Dead cells were excluded based on forward
and side scatter characteristics. Upper: CD11c+ cells were gated on CD11b+ CD4+ to deter-
mine tetraspanin expression on CD4+ DCs. Middle: CD11c+ CD11b- CD8α+ cells were
selected for tetraspanin expression analyses. Lower, pDCs: B220+ CD11cint. cells were gated on
CD8α+ for tetraspanin expression analyses.
(TIF)
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